scholarly article | Q13442814 |
P2093 | author name string | Jie Pan | |
Xiaojie Wang | |||
Pan Chi | |||
Songfei Shen | |||
Xingrong Lu | |||
Yanwu Sun | |||
Zongbin Xu | |||
P2860 | cites work | Is human kallikrein-11 in gastric cancer treated with surgery and adjuvant chemoradiotherapy associated with survival? | Q44416612 |
Diagnostic and prognostic significance of human kallikrein 11 (KLK11) mRNA expression levels in patients with laryngeal cancer | Q48004808 | ||
Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry. | Q54369095 | ||
Colorectal cancer | Q55924124 | ||
Phase III Study of Capecitabine Plus Oxaliplatin Compared With Continuous-Infusion Fluorouracil Plus Oxaliplatin As First-Line Therapy in Metastatic Colorectal Cancer: Final Report of the Spanish Cooperative Group for the Treatment of Digestive Tumor | Q58614884 | ||
KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patients | Q62606052 | ||
Colorectal cancer | Q84625527 | ||
Mechanisms of multidrug resistance in cancer | Q84966118 | ||
Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region | Q24290448 | ||
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial | Q24647888 | ||
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
Emerging roles of caspase-3 in apoptosis | Q28141417 | ||
Molecular cloning and expression of a variant form of hippostasin/KLK11 in prostate | Q28204474 | ||
Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer | Q28308193 | ||
MicroRNA-218 enhances the radiosensitivity of human cervical cancer via promoting radiation induced apoptosis | Q33628432 | ||
Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis | Q33779488 | ||
Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis | Q34303405 | ||
Significance of human epidermal growth factor receptor 2 expression in colorectal cancer | Q34585338 | ||
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer | Q34590724 | ||
Colorectal cancer statistics, 2014. | Q34660408 | ||
Syndecan-1 expression is associated with tumor size and EGFR expression in colorectal carcinoma: a clinicopathological study of 230 cases | Q34942792 | ||
Super-compact treatment with a high dose of moxifloxacin in patients with drug-resistant tuberculosis and its resistance mechanisms | Q35159676 | ||
Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis | Q35162606 | ||
Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases | Q35589315 | ||
Towards a pan-European consensus on the treatment of patients with colorectal liver metastases | Q36563821 | ||
Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/Bax | Q36646046 | ||
Prognostic value and biological role of the kallikrein-related peptidases in human malignancies | Q37690308 | ||
Serum lactate dehydrogenase levels as a predictive marker of oxaliplatin-induced hypersensitivity reactions in Japanese patients with advanced colorectal cancer | Q37730274 | ||
microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma | Q39268741 | ||
Identification of HOXB8 and KLK11 expression levels as potential biomarkers to predict the effects of FOLFOX4 chemotherapy | Q39424233 | ||
P433 | issue | 5 | |
P921 | main subject | colorectal cancer | Q188874 |
oxaliplatin | Q422327 | ||
P304 | page(s) | 2855-2860 | |
P577 | publication date | 2016-09-20 | |
P1433 | published in | Experimental and Therapeutic Medicine | Q23979083 |
P1476 | title | Knockdown of KLK11 inhibits cell proliferation and increases oxaliplatin sensitivity in human colorectal cancer | |
P478 | volume | 12 |
Q57790170 | Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patterns |
Q64971114 | Kallikrein 12 Regulates Innate Resistance of Murine Macrophages against Mycobacterium bovis Infection by Modulating Autophagy and Apoptosis. |
Q53705298 | Knockdown of KLK11 reverses oxaliplatin resistance by inhibiting proliferation and activating apoptosis via suppressing the PI3K/AKT signal pathway in colorectal cancer cell. |